| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-10182 |
Laduviglusib |
|
99.76% |
Unkown |
| HY-114180 |
RU.521 |
Inhibitor |
99.95% |
Unkown |
| HY-100564 |
2',3'-cGAMP |
Activator |
99.95% |
Unkown |
| HY-100564A |
2',3'-cGAMP sodium |
Activator |
99.89% |
Unkown |
| HY-12512 |
cGAMP |
Activator |
99.22% |
Unkown |
| HY-136769 |
Biotin-HPDP |
|
99.73% |
Unkown |
| HY-133916 |
G140 |
Inhibitor |
99.17% |
Unkown |
| HY-10583G |
Y-27632 dihydrochloride (GMP) |
Inhibitor |
/ |
Unkown |
| HY-10182G |
Laduviglusib (GMP) |
|
/ |
Unkown |
| HY-110382 |
Cyclic-di-GMP disodium |
Activator |
98.78% |
Unkown |
| HY-128583 |
G150 |
Inhibitor |
99.20% |
Unkown |
| HY-10431G |
SB-431542 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-110385 |
cGAMP disodium |
Activator |
98.47% |
Unkown |
| HY-111673 |
8-CPT-Cyclic AMP sodium |
|
99.92% |
Unkown |
| HY-113469 |
Cyclic GMP |
|
99.77% |
Unkown |
| HY-15575G |
VcMMAE (GMP) |
|
/ |
Unkown |
| HY-13012G |
RepSox (GMP) |
Inhibitor |
/ |
Unkown |
| HY-114182 |
PF-06928215 |
Inhibitor |
99.68% |
Unkown |
| HY-107413 |
SR11237 |
|
99.99% |
Unkown |
| HY-107780B |
Cyclic-di-GMP diammonium |
Activator |
99.07% |
Unkown |
| HY-137662 |
5'-Phosphoguanylyl-(3',5')-guanosine |
Control |
95.77% |
Unkown |
| HY-10182R |
Laduviglusib (Standard) |
|
99.52% |
Unkown |
| HY-101835 |
Decoyinine |
Inhibitor |
99.96% |
Unkown |
| HY-113469A |
Cyclic GMP sodium |
|
99.89% |
Unkown |
| HY-12071G |
LDN193189 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13027G |
DAPT (GMP) |
Inhibitor |
/ |
Unkown |
| HY-12379 |
NS-2028 |
Inhibitor |
99.58% |
Unkown |
| HY-107202GL |
Polyinosinic-polycytidylic acid (GMP Like) |
|
90.5% |
Unkown |
| HY-10432G |
A 83-01 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13257G |
Thiazovivin (GMP) |
Inhibitor |
/ |
Unkown |
| HY-160546 |
cGAS-IN-2 |
Inhibitor |
99.67% |
Unkown |
| HY-B0445GL |
NAD+ (GMP Like) |
|
99.79% |
Unkown |
| HY-149526 |
cGAS-IN-1 |
Inhibitor |
98.21% |
Unkown |
| HY-P0229 |
Ribonuclease T1, Aspergillus oryzae |
|
/ |
Unkown |
| HY-15108G |
Purmorphamine (GMP) |
Agonist |
/ |
Unkown |
| HY-114181 |
IRAK4-IN-4 |
Inhibitor |
99.55% |
Unkown |
| HY-170362 |
cGAS-IN-4 |
Inhibitor |
99.28% |
Unkown |
| HY-A0070AG |
Liothyronine (GMP) |
Agonist |
/ |
Unkown |
| HY-W013111 |
2′-Deoxy-GDP trisodium |
Inhibitor |
98.78% |
Unkown |
| HY-15001G |
Stemregenin 1 (GMP) |
Antagonist |
/ |
Unkown |
| HY-N1938 |
D(+)-Raffinose pentahydrate |
|
≥98.0% |
Unkown |
| HY-P5979 |
LRRKtide |
Substrate |
99.94% |
Unkown |
| HY-W010759 |
Inosine-5′-monophosphate disodium salt octahydrate |
|
98.0% |
Unkown |
| HY-124700 |
LYPLAL1-IN-1 |
|
99.9% |
Unkown |
| HY-400882 |
Tosylate-DPA-714 |
Ligand |
98.78% |
Unkown |
| HY-10219G |
Rapamycin (GMP) |
|
/ |
Unkown |
| HY-174802 |
XL-3158 |
Inhibitor |
99.55% |
Unkown |
| HY-13912G |
IWP-2 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-14648G |
Dexamethasone (GMP) |
Agonist |
/ |
Unkown |
| HY-50723 |
3-Methylxanthine |
|
99.45% |
Unkown |
| HY-13418G |
Dorsomorphin dihydrochloride (GMP) |
Inhibitor |
/ |
Unkown |
| HY-15147G |
XAV-939 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-110385A |
cGAMP diammonium |
Activator |
96.63% |
Unkown |
| HY-112486G |
TA-316 (GMP) |
Agonist |
/ |
Unkown |
| HY-13631EG |
Deruxtecan (GMP) |
|
/ |
Unkown |
| HY-Y0320GL |
Dimethyl sulfoxide (GMP Like) |
Inhibitor |
99.99% |
Unkown |
| HY-112754AGL |
DOTAP chloride (GMP Like) |
|
/ |
Unkown |
| HY-15141G |
Staurosporine (GMP) |
Inhibitor |
/ |
Unkown |
| HY-110397G |
KP-457 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-50723R |
3-Methylxanthine (Standard) |
|
99.58% |
Unkown |
| HY-10219GL |
Rapamycin (GMP Like) |
|
98.8% |
Unkown |
| HY-170362A |
(R)-cGAS-IN-4 |
Control |
99.94% |
Unkown |
| HY-P1179A |
Guanylin(human) TFA |
Activator |
98.54% |
Unkown |
| HY-148748G |
Butyzamide (GMP) |
Activator |
/ |
Unkown |
| HY-107780 |
Cyclic-di-GMP |
Activator |
98.18% |
Unkown |
| HY-12318G |
IBMX (GMP) |
Inhibitor |
/ |
Unkown |
| HY-15659G |
Wnt-C59 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-100933 |
MY-5445 |
Inhibitor |
99.79% |
Unkown |
| HY-108548 |
Rp-8-Br-PET-cGMPS sodium |
Inhibitor |
99.42% |
Unkown |
| HY-123468 |
HA-1004 |
Inhibitor |
99.04% |
Unkown |
| HY-P0229A |
Ribonuclease T1 (animal free) |
|
/ |
Unkown |
| HY-P1179 |
Guanylin(human) |
Activator |
99.77% |
Unkown |
| HY-100564BS |
2',3'-cGAMP-d8 ammonium |
|
99.90% |
Unkown |
| HY-134541GL |
SM-102 (GMP Like) |
|
/ |
Unkown |
| HY-N0737AG |
Harmine (GMP) |
Inhibitor |
/ |
Unkown |
| HY-N5134S2 |
5'-Guanylic acid-15N5 dilithium |
|
99.33% |
Unkown |
| HY-113469B |
Cyclic GMP TBAOH |
|
/ |
Unkown |
| HY-112764GL |
mPEG2000-DMG (GMP Like) |
|
99.86% |
Unkown |
| HY-119808 |
Terrein |
|
99.44% |
Unkown |
| HY-130530 |
AP-C5 |
|
99.30% |
Unkown |
| HY-17447AG |
Tranylcypromine hydrochloride (GMP) |
Inhibitor |
/ |
Unkown |
| HY-W000423G |
DBCO-amine (GMP) |
|
/ |
Unkown |
| HY-W654000 |
Cyclic GMP-13C,15N2 |
|
98.81% |
Unkown |
| HY-15764G |
A 419259 (GMP) |
|
/ |
Unkown |
| HY-178589A |
Biotin-7-GMP lithium solution (100 mM ± 3 mM) |
|
99.99% |
Unkown |
| HY-78932G |
Dap-NE hydrochloride (GMP) |
|
/ |
Unkown |
| HY-10475G |
AM580 (GMP) |
Agonist |
/ |
Unkown |
| HY-12323G |
ISX-9 (GMP) |
Activator |
/ |
Unkown |
| HY-100224G |
SANT-1 (GMP) |
|
/ |
Unkown |
| HY-100374G |
Val-Cit-PAB-MMAE (GMP) |
|
/ |
Unkown |
| HY-10181G |
Dasatinib (GMP) |
|
/ |
Unkown |
| HY-114548 |
Ebselen oxide |
Inhibitor |
98.0% |
Unkown |
| HY-115745 |
Calmodulin antagonist-1 |
Antagonist |
98.0% |
Unkown |
| HY-119611A |
Thioquinapiperifil dihydrochloride |
Inhibitor |
99.22% |
Unkown |
| HY-119819 |
Psicofuranine |
Inhibitor |
98.0% |
Unkown |
| HY-134541G |
SM-102 (GMP) |
|
/ |
Unkown |
| HY-134919 |
CU-76 |
Inhibitor |
97.6% |
Unkown |
| HY-13506G |
M344 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-135110 |
Rp-8-Br-cGMPS sodium |
|
99.9% |
Unkown |
| HY-15682G |
TTNPB (GMP) |
Agonist |
/ |
Unkown |
| HY-78738G |
MC-Val-Cit-PAB (GMP) |
|
/ |
Unkown |
| HY-78921AG |
Fmoc-3VVD-OH (GMP) |
|
/ |
Unkown |
| HY-B0185G |
Lidocaine (GMP) |
|
/ |
Unkown |
| HY-W767865 |
Cyclic GMP sodium-13C5 |
|
99.03% |
Unkown |
| HY-Y0850AGL2 |
Polyvinyl alcohol, MW 64000 (GMP Like) |
|
/ |
Unkown |
| HY-178589 |
Biotin-7-GMP |
|
/ |
Unkown |
| HY-W507009 |
L-Arginyl-L-alanine |
|
99.75% |
Unkown |
| HY-10182C |
Laduviglusib dihydrochloride |
|
/ |
Unkown |
| HY-15371G |
Forskolin (GMP) |
|
/ |
Unkown |
| HY-15582G |
Auristatin E (GMP) |
Inhibitor |
/ |
Unkown |
| HY-78931G |
Boc-Dap-NE (GMP) |
|
/ |
Unkown |
| HY-10407G |
SU 5402 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-12186G |
3-Deazaneplanocin A hydrochloride (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13319G |
JNK-IN-8 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13526G |
YO-01027 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-15578G |
McMMAF (GMP) |
|
/ |
Unkown |
| HY-15579BG |
MMAF sodium (GMP) |
Inhibitor |
/ |
Unkown |
| HY-15579G |
MMAF (GMP) |
Inhibitor |
/ |
Unkown |
| HY-16700G |
PNU-159682 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-184095 |
Iptocigistat |
Inhibitor |
/ |
Unkown |
| HY-50751G |
Linifanib (GMP) |
Inhibitor |
/ |
Unkown |
| HY-U00449G |
AGN 193109 (GMP) |
Antagonist |
/ |
Unkown |
| HY-100596G |
AS1842856 (GMP) |
Inducer |
/ |
Unkown |
| HY-101445G |
Trolox (GMP) |
|
/ |
Unkown |
| HY-101570G |
Nedisertib (GMP) |
Inhibitor |
/ |
Unkown |
| HY-10181GL |
Dasatinib (GMP Like) |
|
/ |
Unkown |
| HY-10221G |
Vorinostat (GMP) |
Inhibitor |
/ |
Unkown |
| HY-10227G |
Bortezomib (GMP) |
|
/ |
Unkown |
| HY-10320G |
Doramapimod (GMP) |
Inhibitor |
/ |
Unkown |
| HY-10321G |
PD173074 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-10585AG |
Valproic acid sodium (GMP) |
|
/ |
Unkown |
| HY-106110 |
OP-2507 |
|
/ |
Unkown |
| HY-106235 |
LB80317 |
Inhibitor |
/ |
Unkown |
| HY-107413G |
SR11237 (GMP) |
|
/ |
Unkown |
| HY-107614G |
1-Oleoyl lysophosphatidic acid sodium (GMP) |
Activator |
/ |
Unkown |
| HY-10966G |
SB-590885 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-110382S |
Cyclic-di-GMP-13C20,15N10 disodium |
Activator |
/ |
Unkown |
| HY-112005G |
DOPE (GMP) |
Inhibitor |
/ |
Unkown |
| HY-112005GL |
DOPE (GMP Like) |
|
/ |
Unkown |
| HY-112251GL |
D-Lin-MC3-DMA (GMP Like) |
|
/ |
Unkown |
| HY-112348 |
HA-1004 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-116705G |
2-Deoxy-2-fluoro-L-fucose (GMP) |
Inhibitor |
/ |
Unkown |
| HY-119611 |
Thioquinapiperifil |
Inhibitor |
/ |
Unkown |
| HY-12041G |
SP600125 (GMP) |
|
/ |
Unkown |
| HY-12238G |
IWR-1 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-12278G |
K02288 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-12292G |
IM-12 (GMP) |
|
/ |
Unkown |
| HY-12299G |
WH-4-023 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-12305G |
Q-VD-OPh (GMP) |
Inhibitor |
/ |
Unkown |
| HY-12362G |
Val-cit-PAB-OH (GMP) |
|
/ |
Unkown |
| HY-12519G |
Oltipraz (GMP) |
|
/ |
Unkown |
| HY-126675G |
AS2863619 (GMP) |
|
/ |
Unkown |
| HY-12879G |
IWP-4 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-128952G |
Tesirine (GMP) |
|
/ |
Unkown |
| HY-129670 |
KMUP-1 |
|
/ |
Unkown |
| HY-13067G |
Celastrol (GMP) |
|
/ |
Unkown |
| HY-131817 |
5'-GMPS |
|
/ |
Unkown |
| HY-131833G |
Fmoc-Gly-Gly-Phe-OH (GMP) |
|
/ |
Unkown |
| HY-131990G |
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (GMP) |
|
/ |
Unkown |
| HY-13227G |
SD-208 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13259G |
MG-132 (GMP) |
|
/ |
Unkown |
| HY-13271AG |
Tubastatin A (GMP) |
|
/ |
Unkown |
| HY-134242 |
6-T-5'-GMP disodium |
|
/ |
Unkown |
| HY-134242A |
6-T-5'-GMP |
|
/ |
Unkown |
| HY-13441G |
(-)-Blebbistatin (GMP) |
Inhibitor |
/ |
Unkown |
| HY-135146G |
GSK-3484862 (GMP) |
|
/ |
Unkown |
| HY-13642G |
RG108 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13689G |
Go 6983 (GMP) |
|
/ |
Unkown |
| HY-137662A |
5'-Phosphoguanylyl-(3',5')-guanosine trisodium |
Control |
/ |
Unkown |
| HY-138300GL |
ALC-0159 (GMP Like) |
|
/ |
Unkown |
| HY-138794G |
XL177A (GMP) |
Inhibitor |
/ |
Unkown |
| HY-13990G |
NVP-TNKS656 (GMP) |
|
/ |
Unkown |
| HY-141520G |
ART558 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-14176G |
Compound E (GMP) |
Inhibitor |
/ |
Unkown |
| HY-14397G |
Indomethacin (GMP) |
Inhibitor |
/ |
Unkown |
| HY-14398G |
Celecoxib (GMP) |
Inhibitor |
/ |
Unkown |
| HY-145973AGL |
3'OMe-m7GpppAmpG ammonium solution (100 mM) (GMP Like) |
Inhibitor |
/ |
Unkown |
| HY-145974AGL |
m7GpppAmpG ammonium solution (100 mM) (GMP like) |
|
/ |
Unkown |
| HY-14823G |
Sobetirome (GMP) |
Agonist |
/ |
Unkown |
| HY-15149G |
Romidepsin (GMP) |
|
/ |
Unkown |
| HY-15244G |
Alpelisib (GMP) |
|
/ |
Unkown |
| HY-153209G |
Adjuvant-4 (GMP) |
|
/ |
Unkown |
| HY-155337 |
eIF4E-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-156087 |
Cholicamideβ |
Inducer |
/ |
Unkown |
| HY-156087G |
Cholicamideβ (GMP) |
Inducer |
/ |
Unkown |
| HY-15772G |
Osimertinib (GMP) |
|
/ |
Unkown |
| HY-15772GL |
Osimertinib (GMP Like) |
|
/ |
Unkown |
| HY-15794G |
Nemorubicin (GMP) |
|
/ |
Unkown |
| HY-15825G |
IWP L6 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-15893G |
DMOG (GMP) |
|
/ |
Unkown |
| HY-15947G |
Ravoxertinib (GMP) |
Inhibitor |
/ |
Unkown |
| HY-159642G |
Dabogratinib (GMP) |
Inhibitor |
/ |
Unkown |
| HY-162459 |
cGAS-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-16294G |
LY2090314 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-16561G |
Resveratrol (GMP) |
|
/ |
Unkown |
| HY-16658BG |
Z-VAD-FMK (GMP) |
Inhibitor |
/ |
Unkown |
| HY-16900G |
Rolipram (GMP) |
Inhibitor |
/ |
Unkown |
| HY-16910G |
WIKI4 (GMP) |
|
/ |
Unkown |
| HY-171561G |
DOTAM-Maleimide triTFA (GMP) |
|
/ |
Unkown |
| HY-172533 |
3′,5′-DiOA-dC |
Agonist |
/ |
Unkown |
| HY-17356G |
Fenofibrate (GMP) |
|
/ |
Unkown |
| HY-179624 |
cGAS-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-180211 |
cGAS-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-18733G |
Lipoic acid (GMP) |
|
/ |
Unkown |
| HY-18740 |
Trequinsin |
Inhibitor |
/ |
Unkown |
| HY-18964G |
MG-101 (GMP) |
|
/ |
Unkown |
| HY-18985G |
Phorbol 12,13-dibutyrate (GMP) |
Activator |
/ |
Unkown |
| HY-19318G |
Fmoc-Val-Cit-PAB (GMP) |
|
/ |
Unkown |
| HY-20336G |
Mc-Val-Cit-PABC-PNP (GMP) |
|
/ |
Unkown |
| HY-20457G |
TL8-506 (GMP) |
|
/ |
Unkown |
| HY-42360G |
SMCC (GMP) |
|
/ |
Unkown |
| HY-42972G |
DBCO-acid (GMP) |
|
/ |
Unkown |
| HY-44980G |
Fmoc-Gly-NH-CH2-acetyloxy (GMP) |
|
/ |
Unkown |
| HY-45672G |
Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (GMP) |
|
/ |
Unkown |
| HY-50698G |
BI 2536 (GMP) |
|
/ |
Unkown |
| HY-70044G |
GSK-1070916 (GMP) |
|
/ |
Unkown |
| HY-78736G |
Val-Cit-PAB-OSBT (GMP) |
|
/ |
Unkown |
| HY-B0150G |
Nicotinamide (GMP) |
Inhibitor |
/ |
Unkown |
| HY-B0350AG |
Sodium butyrate (GMP) |
|
/ |
Unkown |
| HY-B0356G |
Ciprofloxacin (GMP) |
|
/ |
Unkown |
| HY-B0377G |
Famotidine (GMP) |
|
/ |
Unkown |
| HY-B0399G |
L-Carnitine (GMP) |
|
/ |
Unkown |
| HY-B0400CGL |
D-Sorbitol, M150 (GMP Like) |
|
/ |
Unkown |
| HY-B0400DGL |
D-Sorbitol, M200 (GMP Like) |
|
/ |
Unkown |
| HY-B0400EGL |
D-Sorbitol, M400 (GMP Like) |
|
/ |
Unkown |
| HY-B0434G |
Ribavirin (GMP) |
Inhibitor |
/ |
Unkown |
| HY-B0450AG |
Ciclopirox olamine (GMP) |
Inhibitor |
/ |
Unkown |
| HY-B0497G |
Niclosamide (GMP) |
Inhibitor |
/ |
Unkown |
| HY-B1402G |
Hydrocortisone hemisuccinate (GMP) |
Inhibitor |
/ |
Unkown |
| HY-B1505G |
Acefylline (GMP) |
|
/ |
Unkown |
| HY-B1511G |
Cyclic AMP (GMP) |
|
/ |
Unkown |
| HY-B2242GL |
Calcium phosphate (GMP Like) |
|
/ |
Unkown |
| HY-E70069GL |
Endo S2, Streptococcus pyogenes (GMP Like) |
|
/ |
Unkown |
| HY-E70441 |
Guanosine kinase |
|
/ |
Unkown |
| HY-N0083G |
Betulin (GMP) |
|
/ |
Unkown |
| HY-N0322GL |
Cholesterol (GMP Like, synthetic) |
|
99.89% |
Unkown |
| HY-N0378AGL |
D-Mannitol, M200 (GMP Like) |
|
/ |
Unkown |
| HY-N0378BGL |
D-Mannitol, M100 (GMP Like) |
|
/ |
Unkown |
| HY-N0390G |
L-Glutamine (GMP) |
Inhibitor |
/ |
Unkown |
| HY-N0565AG |
Doxycycline (hydrochloride) (GMP) |
|
/ |
Unkown |
| HY-N15159 |
Cladophorol A |
Inhibitor |
/ |
Unkown |
| HY-N5134S1 |
5'-Guanylic acid-13C10 dilithium |
|
/ |
Unkown |
| HY-N5134S3 |
5'-Guanylic acid-d12 dilithium |
|
/ |
Unkown |
| HY-P2865 |
Guanylate kinase |
|
/ |
Unkown |
| HY-P2865A |
Guanylate Kinase, Porcine |
|
/ |
Unkown |
| HY-P5072 |
GRP (14-27) (human, porcine, canine) |
Agonist |
/ |
Unkown |
| HY-RS05528 |
GMPS Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W013636AG |
2-Ketoglutaric acid Sodium (GMP) |
Inhibitor |
/ |
Unkown |
| HY-W087187G |
DOTAGA-anhydride (GMP) |
|
/ |
Unkown |
| HY-Y1311G |
Malic acid (GMP) |
|
/ |
Unkown |
| HY-101085G |
SKL2001 (GMP) |
Agonist |
/ |
Unkown |
| HY-107632G |
GYY4137 (GMP) |
|
/ |
Unkown |
| HY-107780A |
Cyclic-di-GMP sodium |
Activator |
/ |
Unkown |
| HY-111582G |
BBIQ (GMP) |
Agonist |
/ |
Unkown |
| HY-112582AGL |
N1-Methylpseudouridine-5′-triphosphate (GMP like) |
|
/ |
Unkown |
| HY-12273G |
DMH-1 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-123468A |
HA-1004 dihydrochloride |
Inhibitor |
/ |
Unkown |
| HY-12848G |
SAG (GMP) |
Agonist |
/ |
Unkown |
| HY-131764 |
2'-O-MB-cGMP sodium |
Inhibitor |
/ |
Unkown |
| HY-133540G |
Maleimide-DOTA (GMP) |
|
/ |
Unkown |
| HY-135110A |
Rp-8-Br-cGMPS |
|
/ |
Unkown |
| HY-138170GL |
ALC-0315 (GMP Like) |
|
99.86% |
Unkown |
| HY-141432G |
NX-1607 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-171020 |
8-Nitro-2'3'cGMP |
|
/ |
Unkown |
| HY-171520 |
2'-O-MOE-GMP |
|
/ |
Unkown |
| HY-171523 |
LNA-GMP |
|
/ |
Unkown |
| HY-172512 |
3'-O-Methylguanosine-5'-monophosphate |
|
/ |
Unkown |
| HY-178557 |
Im-3'-OMe-GMP |
|
/ |
Unkown |
| HY-178572 |
3'-OMe-m7GMP |
|
/ |
Unkown |
| HY-181713 |
Antibiofilm agent-19 |
|
/ |
Unkown |
| HY-183863 |
N-(4-(1H-Pyrazol-1-yl)butyl)-5-(furan-2-yl)isoxazole-3-carboxamide |
|
/ |
Unkown |
| HY-50723S1 |
3-Methylxanthine-d3 |
|
/ |
Unkown |
| HY-B0342GL |
Meglumine (GMP Like) |
|
/ |
Unkown |
| HY-B0764G |
Bucladesine sodium (GMP) |
Activator |
/ |
Unkown |
| HY-N0391G |
L-Citrulline (GMP) |
Inhibitor |
/ |
Unkown |
| HY-N0614GL |
Sucralose (GMP Like) |
|
/ |
Unkown |
| HY-N11522 |
5-Methyluridine 5′-triphosphate |
|
/ |
Unkown |
| HY-N15369 |
3′-GMP |
|
/ |
Unkown |
| HY-N5134A |
ara-GMP |
|
/ |
Unkown |
| HY-N5134S4 |
5'-Guanylic acid-15N5,d12 dilithium |
|
/ |
Unkown |
| HY-N5134S5 |
5'-Guanylic acid-13C10,15N5 dilithium |
|
/ |
Unkown |
| HY-RS20744 |
Gmps Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS27256 |
Gmps Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W011053GL |
Neotame (GMP Like) |
Inducer |
/ |
Unkown |
| HY-W040193GL |
DSPC (GMP Like) |
|
/ |
Unkown |
| HY-W1048843AG |
4-Arm PEG5000-NH2 (GMP) |
|
/ |
Unkown |
| HY-W1048843AGL |
4-Arm PEG5000-NH2 (GMP Like) |
|
/ |
Unkown |